MEDI — Medistim ASA Balance Sheet
0.000.00%
- NOK4.11bn
- NOK4.04bn
- NOK562.60m
- 97
- 17
- 88
- 81
Annual balance sheet for Medistim ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 71.9 | 129 | 144 | 146 | 171 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 61.2 | 79.6 | 114 | 87.6 | 83.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 246 | 306 | 386 | 392 | 429 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 64.7 | 58.9 | 51.3 | 57.3 | 73.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 346 | 403 | 483 | 506 | 575 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 59.5 | 77.6 | 99.8 | 94.3 | 107 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 89 | 97.2 | 115 | 108 | 138 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 257 | 306 | 368 | 398 | 437 |
| Total Liabilities & Shareholders' Equity | 346 | 403 | 483 | 506 | 575 |
| Total Common Shares Outstanding |